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Abstract
Background: Endometriosis (EM) is highly associated with infertility. The precise mechanism underlying EM-associated
infertility remains controversial. This study aimed to investigate the pathogenesis of infertility in women with EM by
comparing FoxP3+ T regulatory cells (Tregs) expression in the eutopic endometrium of infertile women with EM and
endometrium from healthy fertile women.
Methods: As a marker of Tregs, FoxP3 expression was analyzed in eutopic endometrium during the peri-implantation
phase in infertile women with mild EM (n= 7), advanced EM (n= 20), and normally fertile women without EM (n= 20).
FoxP3 mRNA expression was analyzed by quantitative real-time RT-PCR. FoxP3 protein expression was assessed by
immunohistochemistry.
Results: FoxP3 mRNA expression in all infertile patients with EM was significantly higher than the control group
(P< 0.05) by non-parametric Mann–Whitney U-test. Further analysis based on the extent of EM revealed that FoxP3
mRNA expression in infertile patients with advanced EM was significantly higher than the mild EM group and the
control group (P< 0.05). Immunohistochemistry analysis showed predominant positive staining for FoxP3 protein in the
endometrial stroma. In addition, the number of FoxP3+ cells in the eutopic endometrium of infertile women with
advanced EM was marginally higher than the mild EM group and the control group, although the differences were not
statistically significant (P> 0.05) by two-tailed t-tests.
Conclusions: These findings suggest that FoxP3+ Tregs in the peri-implantation endometrium might participate in the
pathogenesis of advanced EM. However, they are not directly involved in the pathogenesis of advanced EM associated
with infertility. The differential expression of FoxP3 in infertile women with mild EM and advanced EM implicates that
notable differences in the uterine immune status are likely involved in the pathogenesis of mild EM associated with
infertility in the peri-implantation endometrium.
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Background
Endometriosis (EM) is a common and benign
gynecological disorder that is highly associated with infer-
tility. It affects approximately 10% to 15% of women of
reproductive age and 25% to 50% of women with infertility.
Moreover, 30% to 50% of women with EM are infertile [1].
Although the mechanisms underlying EM-associated
infertility include abnormal folliculogenesis, elevated oxi-
dative stress, altered immune function and hormonal mi-
lieu in the follicular and peritoneal environments, and
reduced endometrial receptivity, the precise mechanism of
pathogenesis remains controversial. The combination of
these factors leads to poor oocyte quality and impaired
fertilization and implantation [2,3]. Recent studies have
demonstrated that endometrial molecular defects
during the implantation window might be a cause of
EM-associated infertility. Increasing evidence suggests
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that EM patients have an impaired endometrium and/
or an abnormal endometrial environment which make
them functionally unfavorable for implantation and
pregnancy progression [2,4].
CD4+CD25+FoxP3+T regulatory cells (Tregs) are a spe-
cialized subpopulation of T cells that control and sup-
press a range of immune responses, including T-cell
proliferation and activation, macrophage, B cell, DC and
NK cell function, mast cell degranulation, cell prolifera-
tion, and cytokine release. Forkhead box protein 3
(FoxP3) is a member of the forkhead-box/winged-helix
transcription factor family. It is a unique marker of Tregs.
FoxP3 has been reported to be an essential controlling
gene for the development and function of naturally oc-
curring Treg populations.
Accumulating evidence from both experimental and
clinical studies indicates that a balance between regula-
tion and deletion of responder T cells is an effective
strategy to control immune responsiveness after organ or
cell transplantation [5]. Furthermore, FoxP3+ Tregs are
critical for the maintenance of maternal immune toler-
ance as well as the prevention of autoimmunity and
transplantation rejection. Recent studies have demon-
strated links between impaired function or diminished
Treg cell populations and complications during preg-
nancy due to defective implantation or placental insuffi-
ciency [6]. In miscarriage, reduced responsiveness to
pregnancy associated expansion of Treg cell populations,
due to numerically fewer Tregs as well as Treg functional
deficiency, may underpin reduced immunosuppressive
capability [7]. Compared to women with induced abor-
tion, patients experiencing spontaneous abortion exhibit
fewer decidual and peripheral blood CD4+CD25high T
cells recovery. Women experiencing repeated miscar-
riage have been shown to have a reduced number of
Tregs within the peripheral blood CD4
+ pool and reduced
suppressive capacity. Primary unexplained infertility is
also associated with reduced expression of FoxP3 mRNA
in endometrial tissue during mid-secretory phase of the
menstrual cycle, suggesting that impaired differentiation
and/or recruitment of uterine Tregs, even prior to con-
ception, might affect patients’ ability to establish preg-
nancy [8].
A recent study demonstrated that eutopic endometrial
FoxP3 was up-regulated in women with EM, suggesting
that FoxP3 plays a pathogenic role in the formation of EM
[9]. However, very little is known about the role of FoxP3+
Tregs in the pathophysiologic mechanism of EM-associated
infertility and the changes of FoxP3+ Treg population in
different EM stages. In this study, FoxP3 expression in the
endometrium during the peri-implantation phase was
investigated by comparing infertile women with different
stages of EM to normal fertile women. The purpose is to
elucidate the pathogenesis of infertility in EM.
Methods
Patients and samples
All subjects were patients admitted in the Gynecology
Department of the International Peace Maternity and
Child Health Hospital, Shanghai Jiaotong University
(China) between April 2009 and July 2010. There were
27 primary infertile women with regular menstrual cycles
in the study group. All women had visual or biopsy-
proven EM. They had undergone endometrial curettage
and laparoscopic excision of endometriotic ovarian cysts
or endometriotic peritoneal lesions between days 19 and
23 of the cycle. Procedures were performed based on
endometrial histological dating [10] and the first day of
their last menstrual period (LMP). Infertile women with
EM exhibited a minimum 1 year of infertility with a
current desire for conception, no chromosomal anomalies
in either parent, no uterine structural abnormalities, no
thrombophilic disorders, and no contribution of male fac-
tor infertility. The control group consisted of 20 women
without pelvic EM, confirmed during laparoscopic surgery
for para-ovarian cysts or mesosalpinx cysts. All of them
had regular menstrual cycles and successful pregnancies.
Endometrial biopsies from the control group were taken
between days 19 and 23 of the cycle with dating confirmed
by microscopic examination and LMP. All samples were
histologically examined by a histopathology specialist. The
extent of EM was staged according to the revised Ameri-
can Society for Reproductive Medicine classification
(rAFS) system [11].
None of the patients in the study group and control
group had received any hormone therapy within
6 months of the procedure, had experienced a miscar-
riage, or had a history of in vitro fertilization treatment.
All women abstained from intercourse or used barrier
methods of contraception for the period between their
last menses and sample collection. Exclusion criteria
included: history of autoimmune diseases, pelvic inflam-
matory disease, genital tract infection, use of intrauterine
contraception for at least 6 months prior to surgery,
endometrial hyperplasia or endometrial polyps, and con-
comitant adenomyosis and uterine fibroids. All women
in the control group had only one living child and had
no history of spontaneous abortion, ectopic pregnancy,
or preterm delivery.
This study was approved by the human ethics commit-
tee of the International Peace Maternity and Child
Health Hospital. A written informed consent form was
obtained from each participant prior to their inclusion.
Tissue collection
On the day of operation, endometrial tissue was obtained
by curettage. Each biopsy was divided into two portions.
One was snap-frozen in liquid nitrogen and stored at
−80°C until further analysis was performed. The other
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portion was fixed in 10% neutral buffer formalin for 18
to 24 hours and was embedded in paraffin for further
histological dating and immunohistochemical analysis.
Plasma progesterone levels were measured to ensure that
ovulation had occurred.
Tissue processing
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted using Trizol method (Invitrogen)
from the homogenized tissues, and then quantified on a
NanoDrop™ 1000 Spectrophotometer (Thermo scientific
Waltham, MA, USA). The OD260nm/280 nm ratio was
among 1.9 to 2.0. RNA samples were further assessed by
electrophoresis on 1.5% agarose gels, and then visualized
under UV light after ethidium bromide staining. RNA
samples were stored at −80°C in aliquots until use.
cDNA was synthesized with 1 μg total RNA and 1 μl d
(T)18 Oligo using RevertAid First Strand cDNA Synthe-
sis Kit (Fermentas Thermo). Final volume was 20 μl.
FoxP3 transcripts were relatively quantified by real-time
RT-PCR with SYBR-Green master mix (ABI) on 7500
Real-time PCR System (Applied Biosystems, CA, USA).
Reaction mixtures, in a total volume of 10 μl, contained
5 μl SYBR Green, 0.15 μl primer (Table 1), 1 μl cDNA
(10 fold diluted) and 3.85 μl RNase-free water. As a
negative control, H2O was used instead of cDNA. The
PCR was carried out as follows: 95°C for 2 min, 40 cycles
of 95°C for 15 s, and 60°C for 1 min. A melting curve
was performed to check the specificity of amplification.
The relative transcript concentration was calculated by
2-ΔΔCt taking GAPDH as interval standard control.
Each sample was analyzed in triplicate.
Immunohistochemistry
Endometrial tissues were fixed, cut, mounted, deparaffi-
nized, and rehydrate. After blocking with goat serum, the
sections were incubated with the primary murine mono-
clonal anti-human FoxP3 antibody (Abcam, 236A/E7,
Hong Kong) at 4°C overnight (1:50 dilution). After incu-
bation with secondary polyperoxidase-anti-mouse IgG
antibody (MR-biotech, Shanghai, China), a horseradish
peroxidase detection system was applied. Immunoreac-
tivity was detected using the diaminobenzidine tetrahy-
drochloride chromogen (MR-biotech, Shanghai, China).
Sections were counterstained with hematoxylin,
dehydrated and cleared. For a negative control, PBS was
substituted for the primary antibody in the above proto-
cols. A sample of lymph node tissue, known to contain
FoxP3+ cells, was used as a positive control.
The sections were viewed using a light microscope (Zeiss
MIC00958) under× 400 magnification (×40 objective, ×10
ocular). Tregs were characterized by the brown intracellu-
lar staining of FoxP3 antibody in the stroma of the
endometrium. FoxP3+ cell counting was performed on
10 non-overlapping fields for each sample. Each slide
was counted by two different observers blinded to the
tissue origin. The average counting from each observer
was calculated and a mean was calculated.
Statistical analysis
Statistical analysis was performed with GraphPad Prism
Version 5. Biological parameters were presumed to exist
in a normal distribution. Therefore, two-tailed t-tests
were used to test significance, and the results were
reported as means ± SD. As the results for FoxP3 mRNA
expression did not conform to the normal distribution,
the differences among groups were also assessed with a
non-parametric Mann–Whitney U-test, and results were
reported as the median and interquartile range. For all
tests, P< 0.05 was considered statistically significant.
Results
Basic clinical characteristics of patients
The staging of EM in the study group followed the rAFS
classification. Patients were divided into two subgroups as
follows: 7 patients with mild EM (stage I and II), and 20
with advanced EM (stage III and IV). The mean ages of
patients in these two groups were 31.0 years (range, 27–
40 years) and 29.8 years (range, 26–37 years), respectively.
The mean durations of infertility were 2.85 years (range,
1–6 years) and 3.27 years (range, 1–8 years), respectively.
The mean age in the control group (normally fertile
women without EM) was 30.9 years (range, 25–37 years).
No significant differences were noted in age, cycle length
(mild EM 29.98± 1.32 vs. advanced EM 31.01± 1.41 vs.
control 30.10± 1.20 days) or timing of sampling (mild EM
21.07± 1.60 vs. advanced EM 20.97± 1.98 vs. control
21.45± 1.35 days) among these groups. Furthermore,
serum progesterone levels were similar in these groups
(mild EM 50.34± 2.59 vs. advanced EM 51.67± 2.37 vs.
control 52.10 ± 3.02 nmol/L). The demographic details of
the study group and control group are summarized in
Table 2.
Quantitative real-time PCR analysis of FoxP3 mRNA
expression
FoxP3 mRNA expression in the study group (median,
1.09; interquartile range, 0.58-1.43) was significantly
higher than the control group (median, 0.56;
Table 1 Primer sequences
Primer Sequence Genbank
GAPDH 5'- ATGGAAATCCCATCACCATCTT -3'
3'- CGCCCCACTTGATTTTGG -5'
FoxP3 5'-TGCAGGGCAGCTAGGTACTTG -3' NM_014009.3
3'-TCGGAGATCCCCTTTGTCTTATC -5'
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interquartile range, 0.21-0.72; P< 0.05). Further analysis
based on the extent of EM revealed that FoxP3 mRNA
expression in infertile patients with advanced EM (median,
1.20; interquartile range, 0.86-1.95) was significantly higher
than the mild EM group (median, 0.38; interquartile range,
0.21-0.47) and the control group (P< 0.05). The median
level of FoxP3 mRNA in infertile patients with mild EM
was marginally lower than in the control group (0.38 vs.
0.56), although no statistically significant difference was
detected between these two groups (P> 0.05) (Figure 1).
Immunohistochemical staining of FoxP3 protein in human
endometrium
Immunohistochemical staining showed that FoxP3 protein
was predominantly expressed in the endometrial stroma
(Figure 2). Enumeration of FoxP3+ Tregs was expressed as
the mean number (± SD) of FoxP3+ cells per square milli-
meter of endometrium. The number of FoxP3+ cells in
eutopic endometrium of infertile women with advanced
EM (0.79± 0.52) was marginally higher than the mild EM
group (0.50± 0.29) and the control group (0.51± 0.30), al-
though there were no statistically significant differences
among these groups (P> 0.05) (Table 3).
Discussion
The mechanisms by which EM impairs fertility remain
poorly understood. Accumulating evidence indicates that
the eutopic endometrium of women with EM differs
from that of women without EM [12], which may con-
tribute to failure of implantation. A meta-analysis of in-
vitro fertilization and embryo transfer (IVF-ET) trials
showed that women with EM have similar ovulation and
embryo formation rates compared to patients scheduled
for IVF treatment without EM (e.g. blocked fallopian
tubes). However, the implantation rates in women with
EM are 50% lower than those achieved in patients being
treated for other causes of infertility [13]. These results
indicate a receptivity defect within the eutopic endometrium
in women with EM that affects fertility regardless of other
causes of infertility in EM (e.g. adhesions). Gene array stud-
ies have established aberrant gene expression in the endo-
metrium of women with EM compared to those without
EM during the implantation window [14]. Furthermore,
studies indicate that an abnormal inflammatory environ-
ment is present, not only in pelvic endometriotic lesions,
but also in the eutopic endometrium of patients with EM.
Therefore, the decrease in fertility experienced by these
Figure 1 Quantitative real-time RT-PCR analysis of FoxP3 mRNA
expression in peri-implantation phase eutopic endometrium. (a)
Relative expression of FoxP3 mRNA determined by RT-PCR in
peri-implantation phase eutopic endometrium (cycle days 19–23)
from infertile women with endometriosis (n = 27) and normal
fertile women without endometriosis (n = 20). *Significant
difference compared endometriosis group with control group by
the Mann–Whitney U-test (P< 0.05). (b) Relative expression of FoxP3
mRNA determined by RT-PCR in peri-implantation phase eutopic
endometrium (cycle days 19–23) from infertile women with mild
endometriosis (n= 7), advanced endometriosis (n= 20) and normal
fertile women without endometriosis (n= 20). *Significant difference
compared advanced endometriosis group with mild endometriosis
group and control group by the Mann–Whitney U-test (P< 0.05). All
values were expressed as median (range). (EM, infertile women with
endometriosis; Mild EM, infertile women with mild endometriosis;
Advanced EM, infertile women with advanced endometriosis).







Age (years) 31.00 ± 4.31 29.81 ± 3.71 30.92 ± 4.48
Parity 0a 0a 1b
Cycle length (days) 29.98 ± 1.32 31.01 ± 1.41 30.10 ± 1.20
Progesterone level
(nmol/l)
50.34 ± 2.59 51.67 ± 2.37 52.10 ± 3.02
Timing of sampling
(days)
21.07 ± 1.60 20.97 ± 1.98 21.45 ± 1.35
Histroy of infertility
(years)
2.85 ± 2.23 3.27 ± 2.60 0
Values represent mean± SD.
Mild-EM, infertile women with mild endometriosis.
Advanced-EM, infertile women with advanced endometriosis.
a Primary infertility.
b Had only one child.
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women might be caused by inflammatory processes, which
in turn, affecting ovulation and implantation.
Successful embryo implantation is a dynamic process,
requiring dialog between the blastocyst and a receptive
endometrium [15]. Although implantation is primarily
regulated by the steroid hormones, a host of local immune
cells, cytokines, growth factors and adhesion molecules
have been identified that mediate the apposition, adhe-
sion and invasion of the blastocyst [16,17]. Maintenance
of an optimal pro- and anti-inflammatory state at the
feto-maternal interface is necessary for successful im-
plantation. The leukocyte population in the endometrial
environment at the time of implantation includes uter-
ine natural killer (uNK), macrophages, T cells and B
cells [18-20]. Dysregulation in the production of these
factors may lead to aberrant implantation. As one of
these factors, Tregs play a crucial role in regulation and
suppression of local immune response during implantation
phase.
Recently, studies in reproductive immunology show that
Tregs play an important role in maternal tolerance of the
conceptus. Their suppressive actions are exerted even
prior to embryo implantation. Tregs are enriched at the
fetal-maternal interface, showing a suppressive phenotype.
Inadequate numbers of Tregs or their functional deficiency
might be linked with miscarriage, pre-eclampsia, infertility
and the failure of embryo implantation. Several studies
have reported an association between Tregs and im-
plantation failure or recurrent spontaneous miscarriage
in humans. Women experiencing repeated miscarriage
were shown to have a reduced frequency of Tregs within
peripheral blood, and reduced suppressive capacity, com-
pared to normal fertile women [7,21]. Primary unexplained
infertility has also been associated with reduced expression
of Foxp3 mRNA in endometrial tissue in the mid-secretory
phase of the menstrual cycle [8]. These studies suggest
that reduction in the size and functional impairment of
the Treg population and/or insufficient migration of
Tregs to decidual tissue at the feto–maternal interface
induce implantation failure in embryo implantation or
recurrent spontaneous abortion in humans.
In contrast to other leukocytes, Tregs play the most cru-
cial roles in controlling, suppressing and modulating a vast
variety of immune responses in the development of
Table 3 FoxP3 levels in the endometrium
Groups No. FoxP3 (mean± SD)*
Mild-EM 7 0.50 ± 0.29
Advanced-EM 20 0.79 ± 0.52
Control 20 0.51 ± 0.30
Notes: * mean number of FoxP3 + cells per square millimetre of endometrium.
P> 0.05 Mild-EM versus Advanced-EM versus Control.
Mild-EM, infertile women with mild endometriosis.
Advanced-EM, infertile women with advanced endometriosis.
Figure 2 Immunohistochemical staining of FoxP3 protein in peri-implantation phase eutopic endometrium. Immunohistochemical
staining of FoxP3 protein expression in eutopic endometrium during the peri-implantation phase. Positive immunolabeling for FoxP3 (brown
diaminobenzidine chromogen coloration) occurs in the endometrial stroma (arrows). (a) FoxP3 protein expression in the endometrium of infertile
patients with advanced endometriosis. (b) FoxP3 protein expression in the endometrium of infertile patients with mild endometriosis. (c) FoxP3
expression in the endometrium of the control group. No significant difference was observed among these groups. (all pictures, original
magnification× 200; inset, original magnification × 400).
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endometriosis. Endometriosis is an inflammatory condi-
tion, associated with highly dysregulated immune response
at both uterine and peritoneal levels. Recent evidence sug-
gests that dysregulated immune response in EM is likely to
originate within the eutopic endometrium [22]. Berbic
et al. found that FoxP3+ cells in the eutopic endometrium
of women with EM remained highly up-regulated during
the secretory phase of the menstrual cycle, while at this
time their expression was significantly down-regulated in
women without EM [21]. They propose that FoxP3+ cells
in eutopic endometrium in women with EM decrease the
ability of newly recruited immune cell populations to ef-
fectively recognize and target endometrial antigens shed
during menstruation, allowing their survival and ability to
implant in ectopic sites [9]. Tregs are likely to be linked to
pathogenesis and progression of EM. Basta et al. demon-
strated that the disturbance in the immunological equilib-
rium observed in ectopic endometrium and deciduas
would seem to be related to the alteration in the Treg cell
population that occurs in these ectopic tissues. Addition-
ally, no differences in the percentage of Tregs within the T
lymphocyte subpopulation were observed over the course
of the menstrual cycle in the ovarian endometriosis. They
hypothesized that the absence of Tregs fluctuation can be
linked to an immune defect arising with the development
of endometriosis [23]. In another genetic marker research,
André GM et al. first evaluated the association between
FOXP3 polymorphisms in infertile women with and with-
out EM. They suggest that the FOXP3 polymorphisms can
be associated with risk of idiopathic infertility (rs2280883
and rs2232368) and EM (rs3761549) in Brazilian women
[24]. In addition, recent studies have implicated Tregs in in-
ducing tolerance to tumours. In Prieto’s reviews, the pro-
posed hypothesis predicts that local expansion of Tregs
might suppress anti-tumour responses and facilitate the
progression of EM to ovarian cancer in susceptible women
[25].
Very few human studies of FoxP3 expression in the peri-
implantation endometrium have been reported. FoxP3 ex-
pression in the endometrium of infertile patients with EM
compared to healthy fertile women remains to be eluci-
dated. Therefore, this study aimed to study the difference
of FoxP3+ expression in endometrial tissue during the
peri-implantation window between patients with EM-
associated infertility and healthy fertile women. Fur-
thermore, FoxP3 expression in the endometrium of in-
fertile patients with different stages of EM and the role
of Tregs in the etiology of infertility in women with EM
were investigated as well. Analysis of FoxP3 mRNA ex-
pression by quantitative real-time RT-PCR revealed that
infertile women with EM have higher levels of FoxP3
mRNA in eutopic endometrium than the control group.
Further analysis based on the extent of EM revealed
that infertile women with advanced EM have higher
levels of FoxP3 mRNA in eutopic endometrium than
women with mild EM and the control group. The
results of this study conflict with those reported in 2006
by Jasper et al. [8], which demonstrated an association be-
tween unexplained infertility and reduced FoxP3 mRNA
expression in endometrial tissue. However, the results of
this study are consistent with Berbic’s report, which
demonstrated upregulation of FoxP3 expression in eutopic
endometrium in women with EM in the secretory phase
[9]. Therefore, it is hypothesized that FoxP3+ Tregs in the
peri-implantation endometrium participate in the patho-
genesis of EM while they are not directly involved in the
pathogenesis of advanced EM associated infertility.
Additionally, our study showed that the expression of
FoxP3 mRNA in the infertile women with mild EM was
significant lower than patients with advanced EM, but it
was similar to the control group. It is suggested by this re-
sult that the uterine immune status in peri-implantation
endometrium among infertile patients with mild EM is dif-
ferent from that of the advanced EM. This kind of differ-
ence might be involved in the failure of embryo
implantation and the pathogenesis of infertility in the mild
EM. Although there was no statistically significant differ-
ence between the mild EM group and the control group,
FoxP3 mRNA expression in the infertile women with mild
EM was slightly lower. It is not clear whether the inad-
equate numbers of FoxP3+ Tregs in the peri-implantation
endometrium in sub-fertile women with mild EM is
related to the pathogenesis of infertility and unsuccessful
embryo implantation. This needs to be examined in future
studies with large sample size.
Tregs, which comprise only 5-10% of CD4
+T cells in
human,are few in eutopic endometrium and are period-
ically regulated by 17-β-estradiol [21]. Tregs will increase
and exert full suppressive function when they expose to
alloantigen, such as embryo, sperm, and inflammation
[26,27]. Since our study excluded the effect of alloanti-
gen, the level of FoxP3+ cells by semiquantitative immu-
nohistochemical staining was relatively low. Although
there was no statistically significant difference, FoxP3+
expression in the advanced EM group was higher than
the mild EM group and the control group. This result
was consistent with the findings in the quantitative real-
time PCR analysis. Because it is unethical to investigate
human embryo implantation process in vivo, future studies
may focus on the changes of Tregs during peri-implantation
phase in the eutopic endometrium of infertile women with
EM in vitro.
Conclusions
From the above, our findings suggest that FoxP3+ Tregs
in the peri-implantation endometrium might participate
in the pathogenesis of advanced EM. However, they are
not directly involved in the pathogenesis of advanced
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EM associated with infertility. The differential expression
of FoxP3 in infertile women with mild EM and advanced
EM implicates that notable differences in the uterine im-
mune status are likely involved in the pathogenesis of
mild EM associated with infertility in the peri-implantation
endometrium.
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